Mdm2tm1.1Ypz/Mdm2+ Tg(IghMyc)22Bri/0
B6.Cg-Mdm2tm1.1Ypz Tg(IghMyc)22Bri
|
premature death |
J:164200
|
Mdm2tm1.1Ypz/Mdm2tm1.1Ypz Tg(IghMyc)22Bri/0
B6.Cg-Mdm2tm1.1Ypz Tg(IghMyc)22Bri
|
enlarged liver |
J:164200
|
enlarged lymph nodes |
J:164200
|
enlarged Peyer's patches |
J:164200
|
enlarged thymus |
J:164200
|
increased lymphoma incidence |
J:164200
|
premature death |
J:164200
|
spleen hyperplasia |
J:164200
|
Mdm2tm1Bay/Mdm2+ Rpl27aSfa/Rpl27a+
involves: 129S7/SvEvBrd * C57BL/6J
|
prenatal lethality, complete penetrance |
J:174216
|
Mdm2tm1Bay/Mdm2tm1Bay Trp53tm1Brd/Trp53tm1Brd
involves: 129S7/SvEvBrd
|
no abnormal phenotype detected |
J:29811
|
Mdm2tm1Bay/Mdm2tm1Bay Trp53tm1Snj/Trp53tm1Snj
involves: C57BL/6
|
prenatal lethality, complete penetrance |
J:87687
|
Mdm2tm1Bay/Mdm2tm1Bay Trp53tm2.1Kasa/Trp53tm2.1Kasa
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6
|
prenatal lethality, complete penetrance |
J:186335
|
Mdm2tm1Bay/Mdm2tm1Mep Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6
|
abnormal bone marrow cell morphology/development |
J:81065
|
abnormal small intestine morphology |
J:81065
|
decreased mortality induced by ionizing radiation |
J:81065
|
normal
hematopoietic system phenotype |
J:81065
|
Mdm2tm1Glo/Mdm2+ Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6
|
normal
mortality/aging |
J:123661
|
Mdm2tm1Glo/Mdm2+ Mdm4Gt(VICTR20)7Lex/Mdm4+ Trp53tm1Wahl/Trp53tm1Wahl
involves: 129S5/SvEvBrd * 129S7/SvEvBrd * C57BL/6
|
abnormal cell cycle |
J:108183
|
Mdm2tm1Glo/Mdm2+ Mdm4Gt(VICTR20)7Lex/Mdm4+ Trp53tm3Wahl/Trp53tm3Wahl
involves: 129
|
abnormal cell cycle |
J:108183
|
Mdm2tm1Glo/Mdm2+ Trp53tm1Wahl/Trp53tm1Wahl
involves: 129S7/SvEvBrd * C57BL/6
|
abnormal cell cycle |
J:108183
|
Mdm2tm1Glo/Mdm2+ Mdm4tm1Glo/Mdm4+
involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6
|
abnormal cell physiology |
J:123661
|
abnormal cerebellar granule layer morphology |
J:123661
|
abnormal cerebellum external granule cell layer morphology |
J:123661
|
abnormal definitive hematopoiesis |
J:123661
|
abnormal Purkinje cell morphology |
J:123661
|
anemia |
J:123661
|
cerebellum hypoplasia |
J:123661
|
cleft palate |
J:123661
|
decreased body weight |
J:123661
|
decreased bone marrow cell number |
J:123661
|
decreased embryo size |
J:123661
|
decreased erythrocyte cell number |
J:123661
|
decreased fetal size |
J:123661
|
decreased hemoglobin content |
J:123661
|
decreased leukocyte cell number |
J:123661
|
decreased renal glomerulus number |
J:123661
|
exencephaly |
J:123661
|
increased embryonic tissue cell apoptosis |
J:123661
|
kinked tail |
J:123661
|
pallor |
J:123661
|
pancytopenia |
J:123661
|
postnatal lethality, complete penetrance |
J:123661
|
prenatal lethality, incomplete penetrance |
J:123661
|
spleen atrophy |
J:123661
|
spleen hypoplasia |
J:123661
|
thrombocytopenia |
J:123661
|
thymus atrophy |
J:123661
|
thymus hypoplasia |
J:123661
|
Mdm2tm1Glo/Mdm2+ Mdm4tm1Glo/Mdm4+
involves: 129S7/SvEvBrd
|
abnormal Purkinje cell morphology |
J:174216
|
anemia |
J:174216
|
decreased bone marrow cell number |
J:174216
|
decreased cerebellar granule cell number |
J:174216
|
increased foot pad pigmentation |
J:174216
|
normal
mortality/aging |
J:71532
|
small cerebellum |
J:174216
|
Mdm2tm1Glo/Mdm2+ Mdm4tm1Glo/Mdm4+ Trp53tm1Tyj/Trp53+
involves: 129S2/SvPas * 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6
|
normal
mortality/aging |
J:123661
|
Mdm2tm1Glo/Mdm2+ Mdm4tm2.1Glo/Mdm4+
involves: 129S7/SvEvBrd
|
increased foot pad pigmentation |
J:174216
|
Mdm2tm1Glo/Mdm2+ Trp53tm2Wahl/Trp53tm2Wahl
involves: 129S4/SvJae * 129S7/SvEvBrd * C57BL/6
|
abnormal bone marrow morphology |
J:174375
|
decreased erythrocyte cell number |
J:174375
|
decreased leukocyte cell number |
J:174375
|
increased mortality induced by ionizing radiation |
J:174375
|
small thymus |
J:174375
|
spleen atrophy |
J:174375
|
thrombocytopenia |
J:174375
|
Mdm2tm1Glo/Mdm2+ Trp53tm3Wahl/Trp53tm3Wahl
involves: 129S4/SvJae * 129S7/SvEvBrd
|
abnormal cell cycle |
J:108183
|
Mdm2tm1Glo/Mdm2+ Trp53tm1.1Tldo/Trp53+
involves: 129S2/SvPas * 129S7/SvEvBrd * BALB/c * C57BL/6
|
decreased bone marrow cell number |
J:199308
|
decreased telomere length |
J:199308
|
premature death |
J:199308
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm1Adv/Trp53tm1Adv
involves: 129S7/SvEvBrd
|
embryonic lethality between somite formation and embryo turning, complete penetrance |
J:93838
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm1Glo/Trp53tm1Glo
involves: 129S7/SvEvBrd * C57BL/6
|
embryonic lethality, complete penetrance |
J:171821
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm1Glo/Trp53tm4Glo
involves: 129S7/SvEvBrd * C57BL/6
|
decreased body size |
J:171821
|
decreased locomotor activity |
J:171821
|
postnatal lethality, complete penetrance |
J:171821
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm1Tyj/Trp53+
involves: 129S2/SvPas * 129S7/SvEvBrd
|
abnormal embryonic tissue morphology |
J:93838
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S7/SvEvBrd
|
normal
mortality/aging |
J:93838
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6J
|
no abnormal phenotype detected |
J:29810
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm1Wahl/Trp53tm1Wahl
involves: 129S7/SvEvBrd * C57BL/6
|
prenatal lethality, complete penetrance |
J:108183
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm2Glo/Trp53tm2Glo
involves: 129S7/SvEvBrd
|
abnormal Purkinje cell morphology |
J:174216
|
anemia |
J:174216
|
decreased bone marrow cell number |
J:174216
|
decreased cerebellar granule cell number |
J:174216
|
small cerebellum |
J:174216
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm3.1Glo/Trp53+
involves: 129S7/SvEvBrd * C57BL/6
|
prenatal lethality, complete penetrance |
J:95318
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm3.1Glo/Trp53tm4Glo
involves: 129S7/SvEvBrd * C57BL/6
|
normal
mortality/aging |
J:171821
|
Mdm2tm1Glo/Mdm2tm1Glo Trp53tm3Wahl/Trp53tm3Wahl
involves: 129S4/SvJae * 129S7/SvEvBrd
|
prenatal lethality, complete penetrance |
J:108183
|
Mdm2tm1Glo/Mdm2tm2.1Glo Tg(Myh6-cre)2182Mds/0 Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S7/SvEvBrd * FVB/N
|
normal
cardiovascular system phenotype |
J:104114
|
Mdm2tm1Ypz/Mdm2tm1Ypz Trp53tm1Tyj/Trp53+
involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB/N
|
postnatal lethality |
J:126004
|
Mdm2tm1Ypz/Mdm2tm1Ypz Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6 * FVB/N
|
normal
mortality/aging |
J:126004
|
Mdm2tm3.1Glo/Mdm2tm3.1Glo
B6.129S6-Mdm2tm3.1Glo
|
decreased cellular sensitivity to ionizing radiation |
J:164201
|
increased fibroblast proliferation |
J:164201
|
increased lymphoma incidence |
J:164201
|
increased mammary adenocarcinoma incidence |
J:164201
|
increased tumor incidence |
J:164201
|
premature death |
J:164201
|
Mdm2tm3.1Glo/Mdm2tm3.1Glo Trp53tm3.1Glo/Trp53+
B6.129S-Mdm2tm3.1Glo Trp53tm3.1Glo
|
decreased cellular sensitivity to ionizing radiation |
J:164201
|
increased adenocarcinoma incidence |
J:164201
|
increased carcinoma incidence |
J:164201
|
increased fibrosarcoma incidence |
J:164201
|
increased hemangiosarcoma incidence |
J:164201
|
increased histiocytic sarcoma incidence |
J:164201
|
increased leiomyosarcoma incidence |
J:164201
|
increased lipoma incidence |
J:164201
|
increased liver adenocarcinoma incidence |
J:164201
|
increased liver adenoma incidence |
J:164201
|
increased lung adenoma incidence |
J:164201
|
increased lymphoma incidence |
J:164201
|
increased mammary adenocarcinoma incidence |
J:164201
|
increased osteosarcoma incidence |
J:164201
|
increased papilloma incidence |
J:164201
|
increased sarcoma incidence |
J:164201
|
increased squamous cell carcinoma incidence |
J:164201
|
increased tumor incidence |
J:164201
|
premature death |
J:164201
|
Mdm2tm4.1Glo/Mdm2tm4.1Glo
B6.129S6-Mdm2tm4.1Glo
|
normal
cellular phenotype |
J:164201
|
increased sarcoma incidence |
J:164201
|
Mdm2tm4.1Glo/Mdm2tm4.1Glo Trp53tm3.1Glo/Trp53+
B6.129S-Mdm2tm4.1Glo Trp53tm3.1Glo
|
increased adenocarcinoma incidence |
J:164201
|
increased carcinoma incidence |
J:164201
|
increased fibrosarcoma incidence |
J:164201
|
increased histiocytic sarcoma incidence |
J:164201
|
increased liver adenocarcinoma incidence |
J:164201
|
increased lymphoma incidence |
J:164201
|
increased osteosarcoma incidence |
J:164201
|
increased sarcoma incidence |
J:164201
|
increased squamous cell carcinoma incidence |
J:164201
|
Tg(Mdm2)1Snj/0 Trp53tm1Brd/Trp53tm1Brd
involves: 129S7/SvEvBrd * C57BL/6
|
increased hemangiosarcoma incidence |
J:51661
|
increased lymphoma incidence |
J:51661
|
increased medulloblastoma incidence |
J:51661
|
increased osteosarcoma incidence |
J:51661
|
increased squamous cell carcinoma incidence |
J:51661
|